LIXTE BIOTECHNOLOGY HOLDINGS, INC. Balance Sheet
LIXT|4 years of annual SEC 10-K data (FY2011-FY2015)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 4 fiscal years. All figures from audited SEC 10-K filings.
LIXTE BIOTECHNOLOGY HOLDINGS, INC. had $597,975 in total assets and $265,862 in shareholders' equity as of FY2015.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -11.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2015 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|
| Cash & Equivalents | $44.4K | - | - | - |
| Current Assets | $598.0K | $558.0K | $1.8M | $429.8K |
| Total Assets | $598.0K | $558.0K | $1.8M | $429.8K |
| Current Liabilities | $285.6K | $321.8K | $261.2K | $350.7K |
| Shareholders' Equity | $265.9K | $0 | $0 | $0 |